Pharmesis Intl

Jianmin Pharmaceutical Group Co.,Ltd. operates within China, focusing on the production and distribution of traditional Chinese medicines. The company's product line features pediatric pharmaceuticals, prominently sold under its Jianmin and Longmu brand names. In addition to these offerings, Jianmin provides a range of over-the-counter (OTC) drugs, various medical and health products, and consultation services. The firm's main corporate offices are located in Wuhan, China.

Zhongzhi Pharmaceutical Holdings Limited, an investment holding firm based in the People's Republic of China, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing and distribution. Its operations are structured across three main divisions: pharmaceutical production, management of its physical retail pharmacy chain, and its online pharmacy platform. The company offers Chinese patent medicines and traditional Chinese decoction pieces, marketed under prominent brands such as Zeus, Liumian, and Caojinghua. In addition to its core pharmaceutical activities, Zhongzhi also produces and sells food products and traditional Chinese herbs, manages properties, and offers detection and testing services. By the end of 2021, the company managed a network of 398 self-owned retail pharmacies. Of these, 361 were approved for medical insurance payments and are situated in Zhongshan, Guangdong Province, operating under the Zeus brand. Established in 1993, the company's headquarters are also located in Zhongshan, PRC. Crystal Talent Investment Group Limited holds a controlling stake in Zhongzhi Pharmaceutical Holdings Limited.

China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.

Guangzhou Pharmaceutical HoldingsPharmaceuticalsChina

66% match

Guangzhou Pharmaceutical Holdings Co., Ltd. (GPHL) is a Guangzhou-based state-owned pharmaceutical and healthcare conglomerate. It develops, manufactures, distributes, and sells traditional Chinese medicines, chemical medicines, and healthcare products through subsidiaries including Guangzhou Baiyunshan Pharmaceutical Holdings and the Wanglaoji brand, serving hospitals, pharmacies, retailers, and consumers.

Hyphens Pharma International Limited is a Singapore-headquartered pharmaceutical company that develops, licenses, distributes, and markets pharmaceutical and healthcare products. It serves healthcare professionals, hospitals, pharmacies, and consumers across Singapore and other Southeast Asian markets, with a focus on specialty and branded products.

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a Guangzhou-based Chinese pharmaceutical company engaged in the research, manufacture, distribution, and retail of proprietary Chinese medicines, chemical drugs, healthcare products, and related medical products. It serves hospitals, pharmacies, healthcare institutions, and consumers primarily in China.